DTL
AVDL

Dynamic Technology Lab’s Avadel Pharmaceuticals AVDL Stock Holding History

Dynamic Technology Lab’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,439
Closed -$154K – 814
2025
Q2 		$154K Buy
17,439
+2,761
+19% +$24.3K 0.02% 829
2025
Q1 		$115K Buy
+14,678
New +$123K 0.02% 898
2021
Q1 		– Sell
-11,299
Closed -$75K – 1134
2020
Q4 		$75K Sell
11,299
-15,022
-57% -$94K 0.01% 916
2020
Q3 		$133K Sell
26,321
-17,598
-40% -$128K 0.02% 866
2020
Q2 		$355K Buy
+43,919
New +$387K 0.05% 607
2018
Q3 		– Sell
-12,310
Closed -$75K – 1011
2018
Q2 		$75K Buy
+12,310
New +$86.4K 0.01% 914
2018
Q1 		– Sell
-19,697
Closed -$161K – 1036
2017
Q4 		$161K Buy
19,697
+206
+1% +$1.93K 0.03% 899
2017
Q3 		$205K Buy
+19,491
New +$186K 0.03% 900
2016
Q2 		– Sell
-25,175
Closed -$278K – 860
2016
Q1 		$278K Buy
+25,175
New +$250K 0.08% 576

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Dynamic Technology Lab's AVDL Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Avadel Pharmaceuticals (AVDL) in Q3 2025, closing a stake of 17,439 shares — an estimated $154K sold.

Dynamic Technology Lab first reported a position in AVDL in Q1 2016 and held it in 9 quarters. The position peaked at $355K in Q2 2020. 188 funds tracked by Wall St. Rank hold AVDL as of Q3 2025.

  • Dynamic Technology Lab reported no remaining Avadel Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,439 Avadel Pharmaceuticals shares in Q3 2025, an estimated $154K.
  • Dynamic Technology Lab first reported a position in Avadel Pharmaceuticals in Q1 2016 and held it in 9 quarters.
  • Dynamic Technology Lab's Avadel Pharmaceuticals position peaked at $355K in Q2 2020.
  • 188 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.